458 related articles for article (PubMed ID: 34006622)
1. Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes.
Graus F; Vogrig A; Muñiz-Castrillo S; Antoine JG; Desestret V; Dubey D; Giometto B; Irani SR; Joubert B; Leypoldt F; McKeon A; Prüss H; Psimaras D; Thomas L; Titulaer MJ; Vedeler CA; Verschuuren JJ; Dalmau J; Honnorat J
Neurol Neuroimmunol Neuroinflamm; 2021 Jul; 8(4):. PubMed ID: 34006622
[TBL] [Abstract][Full Text] [Related]
2. Recommended diagnostic criteria for paraneoplastic neurological syndromes.
Graus F; Delattre JY; Antoine JC; Dalmau J; Giometto B; Grisold W; Honnorat J; Smitt PS; Vedeler Ch; Verschuuren JJ; Vincent A; Voltz R
J Neurol Neurosurg Psychiatry; 2004 Aug; 75(8):1135-40. PubMed ID: 15258215
[TBL] [Abstract][Full Text] [Related]
3. [Not Available].
Nilsson AC; Ryding M; Poulsen CA; Blaabjerg M
Ugeskr Laeger; 2023 Mar; 185(11):. PubMed ID: 36999285
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes in China.
Cai MT; Qiao S; Lai QL; Zheng Y; Yang F; Fang GL; Shen CH; Zhang YX; Ding MP
Front Immunol; 2022; 13():790400. PubMed ID: 35173717
[TBL] [Abstract][Full Text] [Related]
5. "Non-classical" paraneoplastic neurological syndromes associated with well-characterized antineuronal antibodies as compared to "classical" syndromes - More frequent than expected.
Berger B; Bischler P; Dersch R; Hottenrott T; Rauer S; Stich O
J Neurol Sci; 2015 May; 352(1-2):58-61. PubMed ID: 25824848
[TBL] [Abstract][Full Text] [Related]
6. Updates in the Management of Paraneoplastic Syndrome.
Verma N; Jaffer MH; Kolli AS; Mokhtari S
Semin Neurol; 2024 Feb; 44(1):36-46. PubMed ID: 38183975
[TBL] [Abstract][Full Text] [Related]
7. A single center retrospective study of paraneoplastic neurological syndromes with positive onconeural antibodies.
Fu P; He L; Tang N; Nie Q; Li Z
J Clin Neurosci; 2021 Jul; 89():336-342. PubMed ID: 34119290
[TBL] [Abstract][Full Text] [Related]
8. Paraneoplastic neurological syndrome: growing spectrum and relevance.
Ganaraja VH; Rezk M; Dubey D
Neurol Sci; 2022 Jun; 43(6):3583-3594. PubMed ID: 35460452
[TBL] [Abstract][Full Text] [Related]
9. Real-world application of the updated diagnostic criteria for paraneoplastic neurological syndromes.
Campetella L; Papi C; Sabatelli E; Marini S; Iorio R
J Neuroimmunol; 2022 Nov; 372():577972. PubMed ID: 36202000
[TBL] [Abstract][Full Text] [Related]
10. Paraneoplastic neurological syndromes: unusual presentations of cancer. A practical review.
Braik T; Evans AT; Telfer M; McDunn S
Am J Med Sci; 2010 Oct; 340(4):301-8. PubMed ID: 20460982
[TBL] [Abstract][Full Text] [Related]
11. Paraneoplastic neurological syndromes of the central nervous system: a single institution 7-year case series.
Giammello F; Galletta K; Grillo F; Brizzi T; Cavallaro M; Mormina E; Scelzo E; Allegra C; Stancanelli C; Rodolico C; Musumeci O; Toscano A; Granata F
Acta Neurol Belg; 2023 Aug; 123(4):1355-1369. PubMed ID: 36884202
[TBL] [Abstract][Full Text] [Related]
12. [Clinical characteristics of "classical" and "non-classical" paraneoplastic neurological syndrome].
Lyu XY; Wang GP; Tang QQ; Cheng ZZ; Gui W; Tian YH
Zhonghua Yi Xue Za Zhi; 2021 Mar; 101(9):615-619. PubMed ID: 33685041
[No Abstract] [Full Text] [Related]
13. Paraneoplastic Neurological Syndromes: Transitioning Between the Old and the New.
Gastaldi M; Scaranzin S; Pietro B; Lechiara A; Pesce G; Franciotta D; Lorusso L
Curr Oncol Rep; 2022 Oct; 24(10):1237-1249. PubMed ID: 35476177
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis, diagnosis and treatment of paraneoplastic neurologic syndromes.
Blaes F
Expert Rev Neurother; 2021 Jun; 21(6):675-686. PubMed ID: 33960258
[No Abstract] [Full Text] [Related]
15. Management of paraneoplastic neurological syndromes: report of an EFNS Task Force.
Vedeler CA; Antoine JC; Giometto B; Graus F; Grisold W; Hart IK; Honnorat J; Sillevis Smitt PA; Verschuuren JJ; Voltz R;
Eur J Neurol; 2006 Jul; 13(7):682-90. PubMed ID: 16834698
[TBL] [Abstract][Full Text] [Related]
16. Paraneoplastic neurologic syndrome in the PNS Euronetwork database: a European study from 20 centers.
Giometto B; Grisold W; Vitaliani R; Graus F; Honnorat J; Bertolini G;
Arch Neurol; 2010 Mar; 67(3):330-5. PubMed ID: 20212230
[TBL] [Abstract][Full Text] [Related]
17. Paraneoplastic neurological syndromes in lung cancer patients with or without onconeural antibodies.
Raspotnig M; Vedeler C; Storstein A
J Neurol Sci; 2015 Jan; 348(1-2):41-5. PubMed ID: 25467140
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic yield of commercial immunodots to diagnose paraneoplastic neurologic syndromes.
Déchelotte B; Muñiz-Castrillo S; Joubert B; Vogrig A; Picard G; Rogemond V; Pinto AL; Lombard C; Desestret V; Fabien N; Honnorat J
Neurol Neuroimmunol Neuroinflamm; 2020 May; 7(3):. PubMed ID: 32170044
[TBL] [Abstract][Full Text] [Related]
19. Advances in paraneoplastic neurological syndromes.
Honnorat J; Cartalat-Carel S
Curr Opin Oncol; 2004 Nov; 16(6):614-20. PubMed ID: 15627026
[TBL] [Abstract][Full Text] [Related]
20. Paraneoplastic neurological syndromes associated with non-Hodgkin lymphoma: a case series.
Dinoto A; Cheli M; Catalan M; Olivo S; Scali I; Bertolotti C; Sartori A; Manganotti P
Neurol Sci; 2022 Mar; 43(3):2077-2079. PubMed ID: 35000013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
